GlassScriptPhysician profile
Christopher W Ince
NPI 1780709493
$11,351.69
in general payments reported to CMS, 2019-2025
35 companies · $3,010 in 2025
The $3,010 reported for 2025 was more than what 89% of Pain Medicine (Anesthesiology) providers received nationally (typical 2025 total: $458).
See the full distribution for Pain Medicine (Anesthesiology)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $2,353 · 2020: $1,137 · 2021: $2,075 · 2022: $811 · 2023: $764 · 2024: $1,202 · 2025: $3,010.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,800 · Travel and Lodging: $2,161 · Gift: $15.00.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,800.07 |
| Travel and Lodging | $2,161.03 |
| Gift | $15.00 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Spinal Simplicity, LLC | $2,732.42 | 2021-2025 | Ha Minuteman G3-R |
| Abbott Laboratories | $1,541.96 | 2019-2025 | Proclaim |
| Genesys Orthopedics Systems, L.L.C. | $1,302.76 | 2025 | Sacroiliac Joint Fusion System |
| Si-Bone, INC. | $927.56 | 2024-2025 | |
| Daiichi Sankyo INC. | $670.86 | 2019 | |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $643.72 | 2019-2025 | Relistor |
| Collegium Pharmaceutical, INC. | $424.20 | 2019-2025 | Xtampza, Belbuca |
| Pfizer INC. | $326.94 | 2019-2021 | |
| Abbvie INC. | $303.10 | 2021-2025 | |
| Amgen INC. | $253.38 | 2019-2022 | |
| Arbor Pharmaceuticals, INC. | $253.31 | 2019-2022 | |
| Spr Therapeutics, INC | $220.53 | 2022-2023 | Sprint Pns System |
| Nevro Corp. | $204.31 | 2019-2020 | |
| Boston Scientific Corporation | $201.22 | 2019-2020 | |
| Almatica Pharma LLC | $185.05 | 2021-2023 | Gralise, Loreev Xr |
Show all 35 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Protega Pharmaceutials INC | $175.82 | 2023-2025 | Roxybond |
| Curonix LLC | $142.22 | 2023 | Pns Freedom-4a Permanent Neurostimulator Receiver Kit Channel A |
| Teva Pharmaceuticals USA, INC. | $109.36 | 2019-2020 | |
| Scilex Pharmaceuticals INC. | $78.67 | 2022-2024 | Ztlido |
| Valinor Pharma, LLC | $72.27 | 2023-2024 | Movantik |
| Assertio Therapeutics, INC. | $64.82 | 2019 | |
| Shionogi INC | $64.52 | 2019 | |
| Biodelivery Sciences International, INC. | $57.67 | 2019-2021 | |
| Upsher-Smith Laboratories LLC | $52.89 | 2020 | |
| Azurity Pharmaceuticals, INC. | $52.66 | 2024-2025 | Horizant |
| Lilly USA, LLC | $45.67 | 2019 | |
| Redhill Biopharma INC. | $38.85 | 2022 | |
| Vertiflex, INC. | $37.93 | 2019 | |
| Horizon Therapeutics Plc | $37.23 | 2019-2022 | |
| Zyla Life Sciences, INC. | $36.28 | 2019 | |
| Astrazeneca Pharmaceuticals LP | $30.97 | 2019 | |
| Vertex Pharmaceuticals Incorporated | $19.28 | 2025 | |
| Ibsa Pharma INC. | $16.00 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $14.00 | 2019 | |
| Allergan, INC. | $13.26 | 2020 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Christopher Ince listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.